Abstract
Mild cognitive impairment (MCI) and Alzheimer’s disease (AD) are associated with a progressive loss of cognitive abilities. In the present report, we assessed the relationship of memory and executive function with brain structure in a sample of 810 Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants, including 188 AD, 396 MCI, and 226 healthy older adults (HC). Composite scores of memory (ADNI-Mem) and executive function (ADNI-Exec) were generated by applying modern psychometric theory to item-level data from ADNI’s neuropsychological battery. We performed voxel-based morphometry (VBM) and surface-based association (SurfStat) analyses to evaluate relationships of ADNI-Mem and ADNI-Exec with grey matter (GM) density and cortical thickness across the whole brain in the combined sample and within diagnostic groups. We observed strong associations between ADNI-Mem and medial and lateral temporal lobe atrophy. Lower ADNI-Exec scores were associated with advanced GM and cortical atrophy across broadly distributed regions, most impressively in the bilateral parietal and temporal lobes. We also evaluated ADNI-Exec adjusted for ADNI-Mem, and found associations with GM density and cortical thickness primarily in the bilateral parietal, temporal, and frontal lobes. Within-group analyses suggest these associations are strongest in patients with MCI and AD. The present study provides insight into the spatially unbiased associations between brain atrophy and memory and executive function, and underscores the importance of structural brain changes in early cognitive decline.
Similar content being viewed by others
References
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270–279.
Amici, S., Ogar, J., Brambati, S. M., Miller, B. L., Neuhaus, J., Dronkers, N. L., et al. (2007). Performance in specific language tasks correlates with regional volume changes in progressive aphasia. Cognitive and Behavioral Neurology, 20(4), 203–211.
Apostolova, L. G., Lu, P., Rogers, S., Dutton, R. A., Hayashi, K. M., Toga, A. W., et al. (2008). 3D mapping of language networks in clinical and pre-clinical Alzheimer’s disease. Brain and Language, 104(1), 33–41.
Apostolova, L. G., Morra, J. H., Green, A. E., Hwang, K. S., Avedissian, C., Woo, E., et al. (2010). Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. NeuroImage, 51(1), 488–499.
Armstrong, R. A. (2009). The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathologica, 47(4), 289–299.
Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry—the methods. NeuroImage, 11(6 Pt 1), 805–821.
Barbeau, E. J., Ranjeva, J. P., Didic, M., Confort-Gouny, S., Felician, O., Soulier, E., et al. (2008). Profile of memory impairment and gray matter loss in amnestic mild cognitive impairment. Neuropsychologia, 46(4), 1009–1019.
Berlingeri, M., Bottini, G., Basilico, S., Silani, G., Zanardi, G., Sberna, M., et al. (2008). Anatomy of the episodic buffer: a voxel-based morphometry study in patients with dementia. Behavioural Neurology, 19(1–2), 29–34.
Braak, H., & Braak, E. (1996). Evolution of the neuropathology of Alzheimer’s disease. Acta Neurologica Scandinavica. Supplementum, 165, 3–12.
Braak, H., Braak, E., & Bohl, J. (1993). Staging of Alzheimer-related cortical destruction. European Neurology, 33(6), 403–408.
Braak, H., Braak, E., Yilmazer, D., de Vos, R. A., Jansen, E. N., & Bohl, J. (1996). Pattern of brain destruction in Parkinson’s and Alzheimer’s diseases. Journal of Neural Transmission, 103(4), 455–490.
Brambati, S. M., Myers, D., Wilson, A., Rankin, K. P., Allison, S. C., Rosen, H. J., et al. (2006). The anatomy of category-specific object naming in neurodegenerative diseases. Journal of Cognitive Neuroscience, 18(10), 1644–1653.
Braskie, M. N., Small, G. W., & Bookheimer, S. Y. (2009). Entorhinal cortex structure and functional MRI response during an associative verbal memory task. Human Brain Mapping, 30(12), 3981–3992.
Cabeza, R. (2008). Role of parietal regions in episodic memory retrieval: the dual attentional processes hypothesis. Neuropsychologia, 46(7), 1813–1827.
Cabeza, R., & Nyberg, L. (2000). Imaging cognition II: an empirical review of 275 PET and fMRI studies. Journal of Cognitive Neuroscience, 12(1), 1–47.
Cabeza, R., Ciaramelli, E., Olson, I. R., & Moscovitch, M. (2008). The parietal cortex and episodic memory: an attentional account. Nature Reviews Neuroscience, 9(8), 613–625.
Cahn-Weiner, D. A., Sullivan, E. V., Shear, P. K., Fama, R., Lim, K. O., Yesavage, J. A., et al. (1999). Brain structural and cognitive correlates of clock drawing performance in Alzheimer’s disease. Journal of International Neuropsychological Society, 5(6), 502–509.
Chang, Y. L., Bondi, M. W., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Jr., Jacobson, M. W., et al. (2010). Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease. Neuropsychologia, 48(5), 1237–1247.
Chang, Y. L., Jacobson, M. W., Fennema-Notestine, C., Hagler, D. J., Jr., Jennings, R. G., Dale, A. M., et al. (2010). Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness. Cerebral Cortex, 20(6), 1305–1313.
Chetelat, G., Desgranges, B., de la Sayette, V., Viader, F., Berkouk, K., Landeau, B., et al. (2003). Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain, 126(Pt 9), 1955–1967.
Chetelat, G., Villemagne, V. L., Pike, K. E., Ellis, K. A., Bourgeat, P., Jones, G., et al. (2011). Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease. Brain, 134(Pt 3), 798–807.
Chiang, G. C., Insel, P. S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S., et al. (2011). Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology, 259(3), 844–851.
Chou, Y. Y., Lepore, N., Avedissian, C., Madsen, S. K., Parikshak, N., Hua, X., et al. (2009). Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer’s disease, mild cognitive impairment and elderly controls. NeuroImage, 46(2), 394–410.
Chou, Y. Y., Lepore, N., Saharan, P., Madsen, S. K., Hua, X., Jack, C. R., et al. (2010). Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiology of Aging, 31(8), 1386–1400.
Cockrell, J. R., & Folstein, M. F. (1988). Mini-Mental State Examination (MMSE). Psychopharmacology Bulletin, 24(4), 689–692.
Convit, A., de Asis, J., de Leon, M. J., Tarshish, C. Y., De Santi, S., & Rusinek, H. (2000). Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease. Neurobiology of Aging, 21(1), 19–26.
Costafreda, S. G., Fu, C. H., Lee, L., Everitt, B., Brammer, M. J., & David, A. S. (2006). A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Human Brain Mapping, 27(10), 799–810.
Crane, P. K., Carle, A., Gibbons L. E., et al. (2012). Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Brain Imaging and Behavior. doi:10.1007/s11682-012-9186-z.
Crane, P. K., Narasimhalu, K., Gibbons, L. E., Pedraza, O., Mehta, K. M., Tang, Y., et al. (2008). Composite scores for executive function items: demographic heterogeneity and relationships with quantitative magnetic resonance imaging. Journal of International Neuropsychological Society, 14(5), 746–759.
Dale, A., Fischl, B., & Sereno, M. (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage, 9(2), 179–194.
Deweer, B., Lehericy, S., Pillon, B., Baulac, M., Chiras, J., Marsault, C., et al. (1995). Memory disorders in probable Alzheimer’s disease: the role of hippocampal atrophy as shown with MRI. Journal of Neurology, Neurosurgery, and Psychiatry, 58(5), 590–597.
Di Paola, M., Macaluso, E., Carlesimo, G. A., Tomaiuolo, F., Worsley, K. J., Fadda, L., et al. (2007). Episodic memory impairment in patients with Alzheimer’s disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. Journal of Neurology, 254(6), 774–781.
Dickerson, B. C., & Wolk, D. A. (2011). Dysexecutive versus amnesic phenotypes of very mild Alzheimer’s disease are associated with distinct clinical, genetic and cortical thinning characteristics. Journal of Neurology, Neurosurgery, and Psychiatry, 82(1), 45–51.
Epstein, N. U., Saykin, A. J., Risacher, S. L., Gao, S., & Farlow, M. R. (2010). Differences in medication use in the Alzheimer’s disease neuroimaging initiative: analysis of baseline characteristics. Drugs & Aging, 27(8), 677–686.
Evans, M. C., Barnes, J., Nielsen, C., Kim, L. G., Clegg, S. L., Blair, M., et al. (2010). Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations. European Radiology, 20(3), 674–682.
Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America, 97(20), 11050–11055.
Fischl, B., Sereno, M., & Dale, A. (1999). Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage, 9(2), 195–207.
Fischl, B., Salat, D., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., et al. (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., et al. (1996). Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study. Brain, 119(Pt 6), 2001–2007.
Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D., et al. (2012). A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging and Behavior. doi:10.1007/s11682-012-9176-1.
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., & Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage, 14(1 Pt 1), 21–36.
Goodglass, H., & Kaplan, E. (1983). The assessment of aphasia and related disorders. Philadelphia: Lea & Febiger.
Goto, M., Abe, O., Miyati, T., Yoshikawa, T., Hayashi, N., Takao, H., et al. (2011). Entorhinal cortex volume measured with 3 T MRI is positively correlated with the Wechsler Memory Scale-Revised logical/verbal memory score for healthy subjects. Neuroradiology, 53(8), 617–622.
Grady, C. L., McIntosh, A. R., Beig, S., Keightley, M. L., Burian, H., & Black, S. E. (2003). Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer’s disease. Journal of Neuroscience, 23(3), 986–993.
Greene, S. J., & Killiany, R. J. (2010). Subregions of the inferior parietal lobule are affected in the progression to Alzheimer’s disease. Neurobiology of Aging, 31(8), 1304–1311.
Greene, S. J., & Killiany, R. J. (2011). Hippocampal subregions are differentially affected in the progression to alzheimer’s disease. Anatomical Record (Hoboken).
Grossman, M., McMillan, C., Moore, P., Ding, L., Glosser, G., Work, M., et al. (2004). What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain, 127(Pt 3), 628–649.
Hackert, V. H., den Heijer, T., Oudkerk, M., Koudstaal, P. J., Hofman, A., & Breteler, M. M. (2002). Hippocampal head size associated with verbal memory performance in nondemented elderly. NeuroImage, 17(3), 1365–1372.
Hamalainen, A., Pihlajamaki, M., Tanila, H., Hanninen, T., Niskanen, E., Tervo, S., et al. (2007). Increased fMRI responses during encoding in mild cognitive impairment. Neurobiology of Aging, 28(12), 1889–1903.
Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science, 297(5580), 353–356.
Hart, J., Jr., Anand, R., Zoccoli, S., Maguire, M., Gamino, J., Tillman, G., et al. (2007). Neural substrates of semantic memory. Journal of International Neuropsychological Society, 13(5), 865–880.
Hirono, N., Mori, E., Ishii, K., Imamura, T., Tanimukai, S., Kazui, H., et al. (2001). Neuronal substrates for semantic memory: a positron emission tomography study in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 12(1), 15–21.
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011). Alzheimer’s disease: the challenge of the second century. Science Translational Medicine, 3(77), 77sr71.
Hua, X., Leow, A. D., Parikshak, N., Lee, S., Chiang, M. C., Toga, A. W., et al. (2008). Tensor-based morphometry as a neuroimaging biomarker for Alzheimer’s disease: an MRI study of 676 AD, MCI, and normal subjects. NeuroImage, 43(3), 458–469.
Huey, E. D., Goveia, E. N., Paviol, S., Pardini, M., Krueger, F., Zamboni, G., et al. (2009). Executive dysfunction in frontotemporal dementia and corticobasal syndrome. Neurology, 72(5), 453–459.
Ino, T., Asada, T., Ito, J., Kimura, T., & Fukuyama, H. (2003). Parieto-frontal networks for clock drawing revealed with fMRI. Neurosciences Research, 45(1), 71–77.
Jack, C. R., Jr., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., et al. (2009). Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain, 132(Pt 5), 1355–1365.
Jagust, W., Gitcho, A., Sun, F., Kuczynski, B., Mungas, D., & Haan, M. (2006). Brain imaging evidence of preclinical Alzheimer’s disease in normal aging. Annals of Neurology, 59(4), 673–681.
Juottonen, K., Laakso, M. P., Insausti, R., Lehtovirta, M., Pitkanen, A., Partanen, K., et al. (1998). Volumes of the entorhinal and perirhinal cortices in Alzheimer’s disease. Neurobiology of Aging, 19(1), 15–22.
Kato, T., Knopman, D., & Liu, H. (2001). Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology, 57, 812–816.
King, R. D., Brown, B., Hwang, M., Jeon, T., & George, A. T. (2010). Fractal dimension analysis of the cortical ribbon in mild Alzheimer’s disease. NeuroImage, 53(2), 471–479.
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey-Bloom, J., Relkin, N., et al. (2001). Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56(9), 1143–1153.
Kovacevic, S., Rafii, M. S., & Brewer, J. B. (2009). High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Disease and Associated Disorders, 23(2), 139–145.
Kramer, J. H., Quitania, L., Dean, D., Neuhaus, J., Rosen, H. J., Halabi, C., et al. (2007). Magnetic resonance imaging correlates of set shifting. Journal of International Neuropsychological Society, 13(3), 386–392.
Laakso, M. P., Soininen, H., Partanen, K., Helkala, E. L., Hartikainen, P., Vainio, P., et al. (1995). Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer’s disease: correlation with memory functions. Journal of Neural Transmission. Parkinson’s Disease and Dementia Section, 9(1), 73–86.
Leow, A. D., Yanovsky, I., Parikshak, N., Hua, X., Lee, S., Toga, A. W., et al. (2009). Alzheimer’s disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. NeuroImage, 45(3), 645–655.
Leube, D. T., Weis, S., Freymann, K., Erb, M., Jessen, F., Heun, R., et al. (2008). Neural correlates of verbal episodic memory in patients with MCI and Alzheimer’s disease—a VBM study. International Journal of Geriatric Psychiatry, 23(11), 1114–1118.
Lo, R. Y., Hubbard, A. E., Shaw, L. M., Trojanowski, J. Q., Petersen, R. C., Aisen, P. S., et al. (2011). Longitudinal change of biomarkers in cognitive decline. Archives of Neurology, 68(10), 1257–1266.
Madsen, S. K., Ho, A. J., Hua, X., Saharan, P. S., Toga, A. W., Jack, C. R., Jr., et al. (2010). 3D maps localize caudate nucleus atrophy in 400 Alzheimer’s disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of Aging, 31(8), 1312–1325.
McDonald, C. R., Gharapetian, L., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jr., Holland, D., et al. (2012). Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiology of Aging, 33(2), 242–253.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944.
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269.
Mechelli, A. P., Price, C. J., Friston, K. J., & Ashburner, J. (2005). Voxel-based morphometry of the human brain: methods and applications. Current Medical Imaging Reviews, 1(1), 1–9.
Minati, L., Edginton, T., Bruzzone, M. G., & Giaccone, G. (2009). Current concepts in Alzheimer’s disease: a multidisciplinary review. American Journal of Alzheimer’s Disease and Other Dementias, 24(2), 95–121.
Mohs, R. C. (1994). Administration and scoring manual for the Alzheimer’s Disease Assessment Scale, 1994 revised edition.
Moll, J., de Oliveira-Souza, R., Moll, F. T., Bramati, I. E., & Andreiuolo, P. A. (2002). The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arquivos de Neuro-Psiquiatria, 60(4), 900–905.
Monchi, O., Petrides, M., Petre, V., Worsley, K., & Dagher, A. (2001). Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. Journal of Neuroscience, 21(19), 7733–7741.
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., et al. (2009). Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain, 132(Pt 5), 1310–1323.
Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., et al. (2009a). Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer’s disease, mild cognitive impairment, and elderly controls. Human Brain Mapping, 30(9), 2766–2788.
Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., et al. (2009b). Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer’s disease, mild cognitive impairment, and elderly controls. NeuroImage, 45(1 Suppl), S3–S15.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43(11), 2412–2414.
Morris, J., Heyman, A., Mohs, R., Hughes, J., van Belle, G., Fillenbaum, G., et al. (1989). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology, 39(9), 1159–1165.
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., et al. (2005a). The Alzheimer’s disease neuroimaging initiative. Neuroimaging Clinics of North America, 15(4), 869–877.
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., et al. (2005b). Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimer’s & Dementia, 1(1), 55–66.
Murphy, E. A., Holland, D., Donohue, M., McEvoy, L. K., Hagler, D. J., Jr., Dale, A. M., et al. (2010). Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. NeuroImage, 53(4), 1310–1317.
Nestor, S. M., Rupsingh, R., Borrie, M., Smith, M., Accomazzi, V., Wells, J. L., et al. (2008). Ventricular enlargement as a possible measure of Alzheimer’s disease progression validated using the Alzheimer’s disease neuroimaging initiative database. Brain, 131(Pt 9), 2443–2454.
Nettiksimmons, J., Harvey, D., Brewer, J., Carmichael, O., DeCarli, C., Jack, C. R., Jr., et al. (2010). Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiology of Aging, 31(8), 1419–1428.
Newman, L. M., Trivedi, M. A., Bendlin, B. B., Ries, M. L., & Johnson, S. C. (2007). The relationship between gray matter morphometry and neuropsychological performance in a large sample of cognitively healthy adults. Brain Imaging and Behavior, 1(1–2), 3–10.
Oh, H., Mormino, E. C., Madison, C., Hayenga, A., Smiljic, A., & Jagust, W. J. (2011). Beta-amyloid affects frontal and posterior brain networks in normal aging. NeuroImage, 54(3), 1887–1895.
Pa, J., Boxer, A., Chao, L. L., Gazzaley, A., Freeman, K., Kramer, J., et al. (2009). Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Annals of Neurology, 65(4), 414–423.
Pa, J., Possin, K. L., Wilson, S. M., Quitania, L. C., Kramer, J. H., Boxer, A. L., et al. (2010). Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. Journal of International Neuropsychological Society, 16(4), 640–650.
Pantel, J., Schonknecht, P., Essig, M., & Schroder, J. (2004). Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer’s dementia. Neuroscience Letters, 361(1–3), 17–20.
Park, H., & Seo, J. (2011). Application of multidimensional scaling to quantify shape in Alzheimer’s disease and its correlation with Mini Mental State Examination: a feasibility study. Journal of Neuroscience Methods, 194(2), 380–385.
Petersen, R. C. (2000). Mild cognitive impairment: transition between aging and Alzheimer’s disease. Neurologia, 15(3), 93–101.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56(3), 303–308.
Petersen, R. C., Jack, C. R., Jr., Xu, Y. C., Waring, S. C., O’Brien, P. C., Smith, G. E., et al. (2000). Memory and MRI-based hippocampal volumes in aging and AD. Neurology, 54(3), 581–587.
Poulin, S. P., Dautoff, R., Morris, J. C., Barrett, L. F., & Dickerson, B. C. (2011). Amygdala atrophy is prominent in early Alzheimer’s disease and relates to symptom severity. Psychiatry Research, 194(1), 7–13.
Rabin, L. A., Saykin, A. J., West, J. D., Borgos, M. J., Wishart, H. A., Nutter-Upham, K. E., et al. (2009). Judgement in older adults with normal cognition, cognitive complaints, MCI, and mild AD: relation to regional frontal grey matter. Brain Imaging and Behavior, 3(2), 212–219.
Reitan, R., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery. Tucson: Neuropsychology Press.
Remy, F., Mirrashed, F., Campbell, B., & Richter, W. (2005). Verbal episodic memory impairment in Alzheimer’s disease: a combined structural and functional MRI study. NeuroImage, 25(1), 253–266.
Rey, A. (1964). L’examen clinique en psychologie. Paris: Presses Universitaires de France.
Risacher, S. L., Saykin, A. J., West, J. D., Shen, L., Firpi, H. A., & McDonald, B. C. (2009). Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Current Alzheimer Research, 6(4), 347–361.
Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., et al. (2010). Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiology of Aging, 31(8), 1401–1418.
Risacher, S. L., Wishart, H. A., & Saykin, A. J. (2011). Functional MRI studies of memory in aging, mild cognitive impairment, and Alzheimer’s disease. In S. H. Faro & F. B. Mohamed (Eds.), Functional neuroradiology (2nd ed.). New York: Springer.
Rombouts, S. A., Barkhof, F., Veltman, D. J., Machielsen, W. C., Witter, M. P., Bierlaagh, M. A., et al. (2000). Functional MR imaging in Alzheimer’s disease during memory encoding. AJNR. American Journal of Neuroradiology, 21(10), 1869–1875.
Rushworth, M. F., Hadland, K. A., Paus, T., & Sipila, P. K. (2002). Role of the human medial frontal cortex in task switching: a combined fMRI and TMS study. Journal of Neurophysiology, 87(5), 2577–2592.
Rusinek, H., De Santi, S., Frid, D., Tsui, W. H., Tarshish, C. Y., Convit, A., et al. (2003). Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. [Research Support, U.S. Gov’t, P.H.S.]. Radiology, 229(3), 691–696.
Sabuncu, M. R., Desikan, R. S., Sepulcre, J., Yeo, B. T., Liu, H., Schmansky, N. J., et al. (2011). The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Archives of Neurology, 68(8), 1040–1048.
Saykin, A. J., Flashman, L. A., Frutiger, S. A., Johnson, S. C., Mamourian, A. C., Moritz, C. H., et al. (1999). Neuroanatomic substrates of semantic memory impairment in Alzheimer’s disease: patterns of functional MRI activation. Journal of International Neuropsychological Society, 5(5), 377–392.
Schmidt-Wilcke, T., Poljansky, S., Hierlmeier, S., Hausner, J., & Ibach, B. (2009). Memory performance correlates with gray matter density in the ento-/perirhinal cortex and posterior hippocampus in patients with mild cognitive impairment and healthy controls—a voxel based morphometry study. NeuroImage, 47(4), 1914–1920.
Shen, K. K., Fripp, J., Meriaudeau, F., Chetelat, G., Salvado, O., & Bourgeat, P. (2011). Detecting global and local hippocampal shape changes in Alzheimer’s disease using statistical shape models. Neuroimage.
Shimamura, A. P. (1995). Memory and the prefrontal cortex. Annals of the New York Academy of Sciences, 769, 151–159.
Small, S. A., Perera, G. M., DeLaPaz, R., Mayeux, R., & Stern, Y. (1999). Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease. Annals of Neurology, 45(4), 466–472.
Smith, C. D., Malcein, M., Meurer, K., Schmitt, F. A., Markesbery, W. R., & Pettigrew, L. C. (1999). MRI temporal lobe volume measures and neuropsychologic function in Alzheimer’s disease. Journal of Neuroimaging, 9(1), 2–9.
Smith, A. B., Taylor, E., Brammer, M., & Rubia, K. (2004). Neural correlates of switching set as measured in fast, event-related functional magnetic resonance imaging. Human Brain Mapping, 21(4), 247–256.
Sperling, R. A., Bates, J. F., Chua, E. F., Cocchiarella, A. J., Rentz, D. M., Rosen, B. R., et al. (2003). FMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74(1), 44–50.
Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., et al. (2010). Functional alterations in memory networks in early Alzheimer’s disease. Neuromolecular Medicine, 12(1), 27–43.
Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests. New York: Oxford University Press.
Stonnington, C. M., Chu, C., Kloppel, S., Jack, C. R., Jr., Ashburner, J., & Frackowiak, R. S. (2010). Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. NeuroImage, 51(4), 1405–1413.
Taylor, S. F., Welsh, R. C., Wager, T. D., Phan, K. L., Fitzgerald, K. D., & Gehring, W. J. (2004). A functional neuroimaging study of motivation and executive function. NeuroImage, 21(3), 1045–1054.
Thomann, P. A., Toro, P., Dos Santos, V., Essig, M., & Schroder, J. (2008). Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer’s disease. Brain and Cognition, 67(1), 88–93.
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., et al. (2009a). MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology, 73(4), 287–293.
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., et al. (2009b). MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology, 73(4), 294–301.
Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Shaw, L. M., Trojanowski, J. Q., et al. (2010). Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Annals of Neurology, 67(3), 308–316.
Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Trojanowski, J. Q., Shaw, L. M., et al. (2010). Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology, 75(2), 143–151.
Vemuri, P., Weigand, S. D., Przybelski, S. A., Knopman, D. S., Smith, G. E., Trojanowski, J. Q., et al. (2011). Cognitive reserve and Alzheimer’s disease biomarkers are independent determinants of cognition. Brain, 134(Pt 5), 1479–1492.
Venneri, A., McGeown, W. J., Hietanen, H. M., Guerrini, C., Ellis, A. W., & Shanks, M. F. (2008). The anatomical bases of semantic retrieval deficits in early Alzheimer’s disease. Neuropsychologia, 46(2), 497–510.
Wager, T. D., Jonides, J., & Reading, S. (2004). Neuroimaging studies of shifting attention: a meta-analysis. NeuroImage, 22(4), 1679–1693.
Walhovd, K. B., Fjell, A. M., Brewer, J., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jr., et al. (2010). Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR. American Journal of Neuroradiology, 31(2), 347–354.
Walhovd, K. B., Fjell, A. M., Dale, A. M., McEvoy, L. K., Brewer, J., Karow, D. S., et al. (2010). Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiology of Aging, 31(7), 1107–1121.
Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation.
Wechsler, D. (1987). Wechsler Memory Scale—revised. New York: Psychological Association.
Weiner, M. W., Aisen, P. S., Jack, C. R., Jr., Jagust, W. J., Trojanowski, J. Q., Shaw, L., et al. (2010). The Alzheimer’s disease neuroimaging initiative: progress report and future plans. Alzheimers Dement, 6(3), 202–211 e207.
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., et al. (2011). The Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement.
Wolk, D. A., & Dickerson, B. C. (2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 107(22), 10256–10261.
Wolk, D. A., & Dickerson, B. C. (2011). Fractionating verbal episodic memory in Alzheimer’s disease. NeuroImage, 54(2), 1530–1539.
Wolz, R., Heckemann, R. A., Aljabar, P., Hajnal, J. V., Hammers, A., Lotjonen, J., et al. (2010). Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI. NeuroImage, 52(1), 109–118.
Zakzanis, K. K., Graham, S. J., & Campbell, Z. (2003). A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer’s type: a neuroimaging profile. Neuropsychology Review, 13(1), 1–18.
Zakzanis, K. K., Mraz, R., & Graham, S. J. (2005). An fMRI study of the Trail Making Test. Neuropsychologia, 43(13), 1878–1886.
Zhang, N., Song, X., Zhang, Y., Chen, W., D’Arcy, R. C., Darvesh, S., et al. (2011). An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer’s disease, mild cognitive impairment, and normal aging: a follow-up study. Journal of Alzheimer’s Disease, 26(Suppl 3), 359–367.
Acknowledgments
Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.
Data analysis was begun at the 2011 Conference on Advanced Psychometric Methods in Cognitive Aging Research, with conference grant support from the National Institute on Aging (NIA) R13 AG030995 (Mungas). Additional support for data management and the specific analyses reported here were provided by NIA R01 AG19771 (Saykin), P30 AG10133 (Saykin/Ghetti), R01 AG029672 (Crane), U01 AG024904 and P30 AG10129 (DeCarli), NSF IIS-1117335 (Shen), and P50 AG05136 (Raskind). SL Risacher was supported by a Clinical and Translational Science Institute (CTSI) Pre-doctoral Training Grant (TL1 RR025759).
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Kwangsik Nho and Shannon L. Risacher contributed equally to this work.
Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (www.adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
Rights and permissions
About this article
Cite this article
Nho, K., Risacher, S.L., Crane, P.K. et al. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease. Brain Imaging and Behavior 6, 551–567 (2012). https://doi.org/10.1007/s11682-012-9203-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-012-9203-2